Mpox Comprehensive Assessment for Responsive Immunisation in Emergency Outbreaks — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Mpox Comprehensive Assessment for Responsive Immunisation in Emergency Outbreaks — Stella

Recruiting

Back to Mpox trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Rwanda

Rwanda Biomedical Center, Kigali

Key details

Sponsor

University of Birmingham

Collaborators

Rwanda Biomedical Centre

Enrollment target

~650 participants

Started

February 2025

Primary completion

December 2026

Age range

5 Years – 80 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov